The Inflation Reduction Act’s Impact on Biomedical Innovation

On September 2, AEI’s Kirsten Axelsen and Brian J. Miller hosted Tess Cameron of RA Capital Management, Nancy Hong of HiTide Venture Capital, and Julia Owens of Sena Therapeutics to discuss the impact that the Inflation Reduction Act’s (IRA) drug-pricing mechanism will have on investment in the biomedical industry and the subsequent creation of new cures for patients.